MedPath

Macrolane Prospective Survey

Withdrawn
Conditions
Females Recently Treated With Macrolane VRF in the Breasts
Registration Number
NCT01223066
Lead Sponsor
Galderma R&D
Brief Summary

The study objective is to evaluate the long term safety when Macrolane Volume Restoration Factor is used in female breasts in clinical practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Females recently treated with Macrolane Volume Restoration Factor in the breasts.
  • Signed informed consent
Exclusion Criteria
  • There are no exclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adverse eventsup to 5 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Akademikliniken

πŸ‡ΈπŸ‡ͺ

Stockholm, Sweden

Β© Copyright 2025. All Rights Reserved by MedPath